Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2020 - 06/30/2020

Lobbyist name	Mary Kaysen
Business name	Bristol-Myers Squibb Company
Address	118 Valley Street
City, state, zip code	Beverly Farms, MA 01915
Country	USA
Agent type	Both
Phone	978-232-1147

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Bristol-Myers Squibb Company

Total amount paid by client; lobbyist is unable to report compensation at activity level: $28,500.00

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	1111	An Act allowing for retail pharmacy discounts and co-pay assistance	Support	$0.00	N/A
Senate Bill	541	An Act relative to co-pay assistance	Support	$0.00	N/A
Senate Bill	1295	An Act to reduce healthcare costs by promoting non-biased prescriber education	Oppose	$0.00	N/A
House Bill	1154	An Act to reduce drug costs through transparency	Oppose	$0.00	N/A
Senate Bill	561	An Act empowering health care consumers	Support	$0.00	N/A
Senate Bill	1352	An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth	Oppose	$0.00	N/A
House Bill	1133	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
Senate Bill	543	An Act reducing health care costs through improved medication management	Support	$0.00	N/A
Senate Bill	1301	An Act to prevent undue influence on prescriber behavior	Oppose	$0.00	N/A
House Bill	1148	An Act regarding Massachusetts drug price relief	Oppose	$0.00	N/A
Senate Bill	552	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
Senate Bill	1304	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Oppose	$0.00	N/A
House Bill	916	An Act relative to co-pay assistance	Support	$0.00	N/A
House Bill	3551	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
Senate Bill	706	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
Senate Bill	2433	An Act relative to step therapy and patient safety	Support	$0.00	N/A
House Bill	926	An Act relative to consumer deductibles	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	712	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Oppose	$0.00	N/A
House Bill	4228	An Act relative to fail first and patient safety	Support	$0.00	N/A
House Bill	1178	An Act relative to promoting transparency in the pharmaceutical industry	Support	$0.00	N/A
Senate Bill	640	An Act to ensure access to generic medications	Neutral	$0.00	N/A
Executive	Executive Office of Health and Human Services (EOHHS)	Monitoring Executive Office of Health & Human Services implementation 101 CMR 801.00: Drug Manufacturer Negotiations and Accountability	Neutral	$0.00	N/A
House Bill	1162	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
Senate Bill	570	An Act relative to out-of-pocket expenses for prescription drug coverage	Support	$0.00	N/A
Senate Bill	2235	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
House Bill	898	An Act relative to consumer deductibles	Oppose	$0.00	N/A
House Bill	3481	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
Senate Bill	703	An Act to define modest meals and refreshments in prescriber education settings	Oppose	$0.00	N/A
House Bill	4000	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
House Bill	1167	An Act relative to prescription drug price transparency	Oppose	$0.00	N/A
Senate Bill	611	An Act to promote value-based insurance design in the Commonwealth	Oppose	$0.00	N/A
House Bill	4134	An Act to improve health care by investing in VALUE	Neutral	$0.00	N/A
House Bill	1193	An Act providing for the establishment of a drug cost review commission	Neutral	$0.00	N/A
Senate Bill	653	An Act relative to prescription drug pricing	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Monitoring Health Policy Commission implementation 958 CMR 12.00, Drug Pricing Review	Neutral	$0.00	N/A
House Bill	1	making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements	Neutral	$0.00	N/A
House Bill	1853	An Act relative to fail first and patient safety	Support	$0.00	N/A
Senate Bill	695	An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern	Oppose	$0.00	N/A
Senate Bill	2397	An Act relative to pharmaceutical access, costs and transparency	Neutral	$0.00	N/A
House Bill	1088	An Act relative to prescription drug access	Support	$0.00	N/A
Senate Bill	3	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	1235	An Act relative to step therapy and patient safety	Support	$0.00	N/A
House Bill	629	An Act relative to pharmaceutical pricing	Oppose	$0.00	N/A
House Bill	1972	An Act to permit the wholesale importation of prescription drugs into the Commonwealth	Oppose	$0.00	N/A
Senate Bill	696	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
Senate Bill	2409	An Act relative to pharmaceutical access, costs and transparency	Neutral	$0.00	N/A
House Bill	949	An Act relative to non-medical switching	Support	$0.00	N/A
House Bill	3801	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	715	An Act relative to pharmaceutical price transparency and cost sharing	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Monitoring the Health Policy Commission implementation of Chapter 363 of the Acts of 2018, An Act Extending the Authorization for the use of certain discount vouchers for prescription drugs	Neutral	$0.00	N/A
House Bill	966	An Act to promote value-based insurance design in the Commonwealth	Oppose	$0.00	N/A
House Bill	3877	An Act relative to capping the price of life saving prescription drugs	Neutral	$0.00	N/A
Senate Bill	1206	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

Date	Recipient name	Office sought	Amount
01/28/2020	Friends of Julian Cyr	Senate – Cape and Islands	$200.00
		Total contributions	$200.00

Close this page

Connect with Us